Announced Tue, 1 Jul · 17:33 IST

Dear Sir/Madam, Pursuant to Regulation 57(5) of SEBI (LODR) Regulations, 2015, please find the attached certificate. You are requested to take the same on record and oblige. Thanking You.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Prism Medico and Pharmacy Ltd has submitted a certificate to BSE in compliance with Regulation 57(5) of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. This regulation requires listed companies to furnish a certificate from the debenture trustee confirming payment of interest or principal on debentures. No specific amounts, dates, or details are mentioned in the filing text itself, as the certificate is attached separately. The submission appears to be a routine compliance formality rather than a new corporate development.

Likely market impact

This is a standard compliance filing related to debenture obligations and is unlikely to have any material impact on the stock price or shareholder value. It signals that the company is meeting its regulatory timelines for debt-related disclosures.